HOB Total Assets from 2010 to 2026
| 688656 Stock | 151.79 4.62 2.95% |
Total Assets | First Reported 2019-12-31 | Previous Quarter 979.3 M | Current Value 965.3 M | Quarterly Volatility 279.2 M |
Check HOB Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HOB Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 47.3 M, Interest Expense of 2.2 M or Selling General Administrative of 78.8 M, as well as many indicators such as . HOB financial statements analysis is a perfect complement when working with HOB Biotech Valuation or Volatility modules.
HOB | Total Assets |
Latest HOB Biotech's Total Assets Growth Pattern
Below is the plot of the Total Assets of HOB Biotech Group over the last few years. Total assets refers to the total amount of HOB Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in HOB Biotech Group books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. HOB Biotech's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HOB Biotech's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1.03 B | 10 Years Trend |
|
Total Assets |
| Timeline |
HOB Total Assets Regression Statistics
| Arithmetic Mean | 434,962,881 | |
| Geometric Mean | 289,869,486 | |
| Coefficient Of Variation | 90.92 | |
| Mean Deviation | 348,588,657 | |
| Median | 225,223,998 | |
| Standard Deviation | 395,484,271 | |
| Sample Variance | 156407.8T | |
| Range | 1.1B | |
| R-Value | 0.84 | |
| Mean Square Error | 49892.7T | |
| R-Squared | 0.70 | |
| Significance | 0.000028 | |
| Slope | 65,569,417 | |
| Total Sum of Squares | 2502524.9T |
HOB Total Assets History
About HOB Biotech Financial Statements
HOB Biotech stakeholders use historical fundamental indicators, such as HOB Biotech's Total Assets, to determine how well the company is positioned to perform in the future. Although HOB Biotech investors may analyze each financial statement separately, they are all interrelated. For example, changes in HOB Biotech's assets and liabilities are reflected in the revenues and expenses on HOB Biotech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in HOB Biotech Group. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Assets | 1.2 B | 594.5 M |
Currently Active Assets on Macroaxis
Other Information on Investing in HOB Stock
HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.